National Comprehensive Cancer Network risk groups . Urology 2014 ; 84 : 386 – 392 . 10.1016/j.urology.2014.05.009 24975710 28. Mahal BA , Aizer AA , Ziehr DR , . The association between insurance status and prostate cancer outcomes
Vinayak Muralidhar, Paul L. Nguyen, Brandon A. Mahal, David D. Yang, Kent W. Mouw, Brent S. Rose, Clair J. Beard, Jason A. Efstathiou, Neil E. Martin, Martin T. King and Peter F. Orio III
Donald A. Podoloff, Douglas W. Ball, Edgar Ben-Josef, Al B. Benson III, Steven J. Cohen, R. Edward Coleman, Dominique Delbeke, Maria Ho, David H. Ilson, Gregory P. Kalemkerian, Richard J. Lee, Jay S. Loeffler, Homer A. Macapinlac, Robert J. Morgan Jr., Barry Alan Siegel, Seema Singhal, Douglas S. Tyler and Richard J. Wong
cancer . Urology 2001 ; 57 : 108 – 111 . 70 Kang DE White RL Jr Zuger JH . Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma . J Urol 2004 ; 171 : 1806 – 1809 . 71
Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Peter E. Clark, Tracy M. Downs, Jason A. Efstathiou, Thomas W. Flaig, Terence Friedlander, Richard E. Greenberg, Khurshid A. Guru, Noah Hahn, Harry W. Herr, Christopher Hoimes, Brant A. Inman, Masahito Jimbo, A. Karim Kader, Subodh M. Lele, Joshua J. Meeks, Jeff Michalski, Jeffrey S. Montgomery, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Michael P. Porter, Mark A. Preston, Wade J. Sexton, Arlene O. Siefker-Radtke, Guru Sonpavde, Jonathan Tward, Geoffrey Wile, Mary A. Dwyer and Lisa A. Gurski
-European Association of Urology (ICUD-EAU), UK National Institute for Health and Care Excellence (NICE), and the AUA/ASCO/ASTRO/SUO. 43 – 45 There is an apparent underutilization of aggressive bladder-preserving therapies for noncystectomy candidates, especially the
E. Allaf, MD a a The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medicine; b Division of Urology, Beth Israel Deaconess Medical Center; and c Department of Urology, Columbia University Medical Center
Peter R. Carroll, J. Kellogg Parsons, Gerald Andriole, Robert R. Bahnson, Erik P. Castle, William J. Catalona, Douglas M. Dahl, John W. Davis, Jonathan I. Epstein, Ruth B. Etzioni, Thomas Farrington, George P. Hemstreet III, Mark H. Kawachi, Simon Kim, Paul H. Lange, Kevin R. Loughlin, William Lowrance, Paul Maroni, James Mohler, Todd M. Morgan, Kelvin A. Moses, Robert B. Nadler, Michael Poch, Chuck Scales, Terrence M. Shaneyfelt, Marc C. Smaldone, Geoffrey Sonn, Preston Sprenkle, Andrew J. Vickers, Robert Wake, Dorothy A. Shead and Deborah A. Freedman-Cass
. Radiology 2013 ; 268 : 461 – 469 . 34. Abdollah F Novara G Briganti A . Trans-rectal versus trans-perineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate? Urology 2011 ; 77 : 921 – 925 . 35
Chunkit Fung, Sophie D. Fossa, Clair J. Beard and Lois B. Travis
losses from male urogenital cancer deaths—United States, 2004 . Urology 2010 ; 76 : 528 – 535 . 5 Bachaud JM Berthier F Soulie M . Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma . Radiother Oncol
Elizabeth R. Plimack and Gary R. Hudes
. J Urol 2007 ; 177 : 1698 - 1702 . 46 Hakimi AA Koi PT Milhoua PM . Renal medullary carcinoma: the Bronx experience . Urology 2007 ; 70 : 878 - 882 . 47 Noguera-Irizarry WG Hibshoosh H Papadopoulos KP . Renal medullary carcinoma: case report
Devon C. Snow and Eric A. Klein
. External validation of the prostate cancer prevention trial risk calculator in a screened population . Urology 2006 ; 68 : 1152 – 1155 . 16. Munekado KM Yoshio N Waturu I . The American urological association symptom index for benign
Stephen A. Rosenberg, David Francis, Craig R. Hullett, Zachary S. Morris, Michael M. Fisher, Jeffrey V. Brower, Kristin A. Bradley, Bethany M. Anderson, Michael F. Bassetti and Randall J. Kimple
-to-Read Health Materials . Available at: https://www.nlm.nih.gov/medlineplus/etr.html . Accessed May 2, 2016 . 10. Colaco M Svider PF Agarwal N . Readability assessment of online urology patient education materials . J Urol 2013 ; 189 : 1048
Michael R. Abern, Richmond A. Owusu, Mark R. Anderson, Edward N. Rampersaud and Brant A. Inman
is listed as optional for men with small-volume, low-grade Ta bladder cancer. The European Association of Urology, however, does recommend that a single dose of immediate postoperative IVC be administered after TUR of a bladder lesion, with additional
